Methods of targeted delivery to a host using a carrier
AssigneeFinncure Oy
InventorErik Johan Niemelä
Life of this patent
Estimating the term…
Abstract
According to some embodiments, a method of providing treatment of a host comprises binding a carrier to cell structures of cells of the host to reduce a likelihood of an agent binding to said cell structures to at least partially inhibits the agent from binding to said cell structures, wherein the carrier comprises a core and a surface functionalized on the core, wherein the functionalized surface bind to target areas of cell structures of the host's cells, and wherein the carrier is to be used as targeted treatment for one or more disease, infections or allergic reactions caused by a disease-causing agent or source.
Claims19
A method of delivery of at least one component to a host, the method comprising:
- introducing the at least one component to the host using a carrier, the carrier comprising a maximum size in at least one dimension in a nanometer or a micrometer range;
- wherein the carrier comprises a core and a functionalized surface configured to increase a binding affinity of the carrier to target cells of the host;
- wherein the carrier is configured to attach to target cells of the host;
- and
- wherein the at least one component is configured to be delivered and released to target cells of the host using the carrier;
- and
- delivering the at least one component to target cells of the host to assist with a prevention or a treatment of a disease or other adverse condition.
A method of delivery of at least one component to a host, the method comprising:
- introducing at least one component within the host using a carrier, the carrier comprising a maximum size in at least one dimension in a nanometer or a micrometer range;
- wherein the carrier comprises a core and a functionalized surface configured to increase a binding affinity of the carrier to target tissue of the host;
- wherein the functionalized surface is configured to specifically bind to target tissue of the host;
- and
- wherein the at least one component is configured to be delivered to target tissue of the host using the carrier;
- and
- delivering the at least one component to target tissue of the host.
Dependencies are inferred from the claim text.